Clinical Trial: Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181525) titled 'Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease' on Aug. 11.

Brief Summary: Inflammatory bowel disease (IBD) is a group of chronic progressive gastrointestinal diseases that can recur throughout life and for which there is no cure. Biologics, the first line of treatment, are not only expensive, but also 30-50% of patients lack response to this type of drug therapy. However, there is a lack of reliable methods to predict the clinical efficacy of biologics. The aim of this study is to construct a reliable model to predict patients' response to biologics therapy b...